Análisis de costo-efectividad de escitalopram comparado con paroxetina, sertralina y venlafaxina como terapia de mantenimiento para pacientes con trastorno de ansiedad generalizada en Colombia

Ceballos, Mateo; Peña, Esperanza; Osorio, Diana Isabel.
Bogotá; IETS; mayo 2016. 53 p. tab, ilus.
Monografia em Espanhol | LILACS, BRISA | ID: biblio-846437

Documentos relacionados

  1. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence.
  2. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
  3. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
  4. Análisis de costo-efectividad de escitalopram comparado con paroxetina, sertralina, fluoxetina y venlafaxina como terapia de mantenimiento para pacientes con trastorno de fobia social en Colombia
  5. Cost-effectiveness analysis of escitalopram compared with paroxetine in treatment of generalized anxiety disorder in the United Kingdom.
  6. Benefit of slow titration of paroxetine to treat depression in the elderly.
  7. Fund Black scientists.
  8. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
  9. Development and Impact of an Institutional Enhanced Recovery Program on Opioid Use, Length of Stay, and Hospital Costs Within an Academic Medical Center: A Cohort Analysis of 7774 Patients.
  10. Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.